Guillain-Barré Syndrome (GBS) — Pathway
Ascending flaccid paralysis + areflexia + CSF albuminocytologic dissociation; IVIG/plasma exchange, serial FVC monitoring to prevent respiratory failure.
Respiratory/bulbar involvement → ICU: ICU. 1) Immunotherapy: IVIG 2 g/kg over 5 days or plasma exchange (as early as possible, equivalent, do not combine; corticosteroids are in…
Step-by-step decision
Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.
🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).
Full pathway
- [Decision] Respiratory/bulbar involvement?Acute ascending flaccid paralysis — respiratory/bulbar involvement or rapid progression? (Acute immune-mediated polyradiculoneuropathy, ~65% with an antecedent infection (1–3 weeks before). Bilateral ascending flaccid paralysis, areflexia ± sensory symptoms; may involve respiratory/bulbar/facial muscles, autonomic (arrhythmia, BP swings). Clinical diagnosis (Asbury), supported by CSF albuminocytologic dissociation (high protein, normal cell count; may take up to 1 week to appear, ~10% negative) + EMG. An emergency, ICU monitoring.)
- Respiratory/bulbar involvement or rapid progression → Respiratory/bulbar involvement → ICU
- Mild, stable, no respiratory involvement → Mild · monitor + immunotherapy
- [End] Mild · monitor + immunotherapyAmbulatory, no respiratory/bulbar involvement: admit for close monitoring — serial forced vital capacity (FVC) and negative inspiratory force (NIF) (q6–8h), cardiac monitoring (autonomic); most moderate–severe cases need immunotherapy (IVIG 2 g/kg over 5 days or plasma exchange, equivalent, do not combine, steroids ineffective). VTE prophylaxis, rehabilitation. Escalate if progressing.
- [End] Respiratory/bulbar involvement → ICUICU. 1) Immunotherapy: IVIG 2 g/kg over 5 days or plasma exchange (as early as possible, equivalent, do not combine; corticosteroids are ineffective). 2) Respiratory monitoring: serial FVC/NIF — FVC <15–20 mL/kg, declining NIF or bulbar weakness with aspiration risk → intubation and mechanical ventilation (do not wait for blood gases to deteriorate). 3) Autonomic: cardiac monitoring, manage arrhythmia/BP swings. 4) VTE prophylaxis, pain management, nutrition, rehabilitation.
Source guidelines & references
- Guillain-Barré syndrome (Merck Manual; AMBOSS); Asbury diagnostic criteria
This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.